v3.25.2
Note 10 - Warrants to Purchase Common Stock
6 Months Ended
Jun. 30, 2025
Notes to Financial Statements  
Outstanding Warrants [Text Block]

10. Warrants to Purchase Common Stock

 

On June 30, 2025, the maturity dates on two accredited investor's Subordinated Notes were extended to December 31, 2025. In connection with the extension, we issued the noteholders warrants exercisable for the purchase of 113 thousand shares of Aemetis, Inc. common stock with a term of two years and an exercise price of $0.01 per share. The warrants were subsequently fully exercised in the third quarter.

 

The following table summarizes warrant activity during the six months ending June 30, 2025:

 

   

Warrants Outstanding & Exercisable

   

Weighted - Average Exercise Price

   

Average Remaining Term in Years

 

Outstanding December 31, 2024

    530     $ 11.70       4.78  

Granted

    226       0.01          

Exercised

    (113 )     0.01          

Outstanding June 30, 2025

    643     $ 9.64       3.88  

 

All of the above outstanding warrants are fully vested and exercisable as of June 30, 2025.

 

The fair value calculations for issued warrants are based on the following weighted average factors:

 

   

For the six months ended June 30,

 

Description

 

2025

   

2024

 

Dividend-yield

    - %     - %

Risk-free interest rate

    3.99 %     4.23 %

Expected volatility

    90.48 %     101.36 %

Expected life (years)

    2.00       2.00  

Exercise price per share

  $ 0.01     $ 0.01  

Market value per share on grant date

  $ 2.59     $ 5.24  

Fair value per share on grant date

  $ 2.58     $ 5.23